Skip to main content

Best FOXO4-DRI Telehealth Providers for Longevity and anti-aging

A D-amino acid retro-inverso peptide designed to disrupt the interaction between FOXO4 and p53 in senescent cells, triggering apoptosis of these 'zombie cells.' A first-in-class senolytic peptide with potential to clear senescent cell burden.

Sarah Chen
Sarah ChenLead Health Editor
Dr. James Okafor, PharmDReviewed by Dr. James Okafor, PharmDPharmD
Updated January 15, 2025
Fact CheckedClinically Reviewed
Updated January 2025 — may be outdated
Anti agingSubcutaneous injectionPrescription Required

What is FOXO4-DRI Used For?

  • Senescent cell clearance
  • Tissue rejuvenation
  • Longevity
  • Age-related inflammation

How FOXO4-DRI Works

FOXO4-DRI is a D-amino acid retro-inverso peptide that disrupts the interaction between FOXO4 (a transcription factor that accumulates in senescent cells) and p53 (the tumor suppressor/apoptosis initiator) in the nuclear compartment. In normal cells, p53 triggers cell death when activated. In senescent 'zombie cells,' FOXO4 sequesters p53 in the nucleus to prevent the cell from dying — keeping it alive but in a chronically inflamed, dysfunctional state (the 'SASP': senescence-associated secretory phenotype). FOXO4-DRI disrupts this interaction, releasing p53 to trigger apoptosis specifically in senescent cells.

What to Expect

Animal studies (van Deursen lab, Nature 2017) show FOXO4-DRI selectively clears senescent cells, restoring fitness, fur density, and kidney function in fast-aging mice within 10 days. Human data is limited to case reports and individual patient experiences. Subjective benefits reported include improved energy, skin quality, and physical function over 4–8 weeks in early human users.

Common Side Effects

  • Injection site reactions
  • Transient fatigue (possible immune activation from cell clearance)
  • Mild flu-like symptoms post-injection (immunological response to senescent cell clearance)
  • Long-term safety profile in humans is not established

This is not a complete list of side effects. Always consult your prescribing physician before starting FOXO4-DRI.

Frequently Asked Questions About FOXO4-DRI

Is FOXO4-DRI safe for human use?

FOXO4-DRI has not completed human clinical trials. Its human use is currently experimental, based primarily on compelling mouse data and a small number of individual case reports. It is available through some compounding pharmacies and longevity-focused physicians who believe the mechanistic rationale warrants carefully supervised use. Informed consent regarding experimental status is essential.

What is a senescent cell and why do they matter?

Senescent cells are cells that have permanently stopped dividing (triggered by DNA damage, telomere shortening, or other stressors) but refuse to die. They accumulate with age and secrete inflammatory cytokines, proteases, and growth factors (the SASP) that damage surrounding healthy tissue and promote systemic inflammation — now recognized as a driver of multiple age-related diseases.

Can FOXO4-DRI be used alongside other senolytics?

Yes. Other senolytic approaches include quercetin + dasatinib (Q+D) and fisetin. Each works through different mechanisms. Combinations may produce additive senescent cell clearance, and some longevity practitioners cycle different senolytics. The safety and optimal combination protocols have not been established in human trials.

How often should FOXO4-DRI be administered?

Based on the mouse research, FOXO4-DRI was used on 3 consecutive days every 10 days. Human protocols reported by early users typically follow a similar intermittent cycle — 3 consecutive days of injection, then a break of 2–4 weeks before repeating. This intermittent approach limits total senescent cell clearance to a controlled pace.

2 Providers Offering FOXO4-DRI

Sorted by lowest price first.

ProviderPriceDoseRatingConsultationLab Testing
Defy Medical

Tampa, FL

$450/per-cycle1-2mg/day (5-day cycle)4.1/5Video TelehealthIncluded
TruLife Health

Scottsdale, AZ

$550/per-cycle1-2mg/day (5-day cycle)4.1/5Video TelehealthIncluded